Holen Sie sich die Stockscreener-App
5.17
6.16%
0.30
Handel nachbörslich:
5.15
-0.02
-0.39%
Schlusskurs vom Vortag:
$4.87
Offen:
$4.91
24-Stunden-Volumen:
108.94K
Relative Volume:
0.87
Marktkapitalisierung:
$292.26M
Einnahmen:
$34.16M
Nettoeinkommen (Verlust:
$-98.43M
KGV:
-2.2094
EPS:
-2.34
Netto-Cashflow:
$-119.33M
1W Leistung:
+5.51%
1M Leistung:
-4.26%
6M Leistung:
-16.07%
1J Leistung:
-12.52%
1-Tages-Spanne:
$4.7201
$5.18
1-Wochen-Bereich:
$4.475
$5.18
52-Wochen-Spanne:
$2.9448
$10.25
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
Firmenname
Foghorn Therapeutics Inc
Sektor
Branche
Telefon
617-586-3100
Adresse
500 TECHNOLOGY SQUARE, CAMBRIDGE
Vergleichen Sie FHTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
5.17 | 266.26M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-23 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-01-30 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-03 | Eingeleitet | Jefferies | Buy |
| 2024-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2023-03-28 | Eingeleitet | BofA Securities | Buy |
| 2023-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-11-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-17 | Eingeleitet | Cowen | Outperform |
| 2020-11-17 | Eingeleitet | Goldman | Buy |
| 2020-11-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-17 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Foghorn Therapeutics Inc Aktie (FHTX) Neueste Nachrichten
Foghorn Therapeutics Inc. stock outlook for YEARWeekly Trade Report & AI Powered Buy/Sell Recommendations - Newser
How sentiment analysis helps forecast Foghorn Therapeutics Inc.2025 Market Outlook & Daily Volume Surge Trade Alerts - Newser
Foghorn Therapeutics’ SWOT analysis: innovative cancer therapy stock faces pivotal trials - Investing.com
Foghorn Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Drop Watch & Intraday High Probability Alerts - Newser
Using flow based indicators on Foghorn Therapeutics Inc.July 2025 Summary & Community Verified Swing Trade Signals - Newser
Is Foghorn Therapeutics Inc. stock ready for a breakout2025 Growth vs Value & Weekly Market Pulse Updates - Newser
Sentiment analysis tools applied to Foghorn Therapeutics Inc.Treasury Yields & AI Powered Trade Plan Recommendations - Newser
How to escape a deep drawdown in Foghorn Therapeutics Inc.Recession Risk & Community Consensus Picks - Newser
Applying Wyckoff theory to Foghorn Therapeutics Inc. stockTrend Confirmation Scanner with Entry Focus - Newser
Leading vs lagging indicators on Foghorn Therapeutics Inc. performanceQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - Newser
Automated trading signals detected on Foghorn Therapeutics Inc.Smart Entry Signals for Active Traders - Newser
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates - MSN
Understanding Foghorn Therapeutics Inc.’s price movementAI Powered Buy Point Forecast Planner - Newser
How cyclical is Foghorn Therapeutics Inc.’s revenue streamFast Growth Mid Cap Picks - sisain.net
Using data filters to optimize entry into Foghorn Therapeutics Inc.Daily Upside Movement Prediction With Data - Newser
Using portfolio simulators with Foghorn Therapeutics Inc. includedGrowth Watchlist for Long Term Positioning - Newser
Comparing Foghorn Therapeutics Inc. in custom built stock radarsShort-Term Swing Opportunity Summary Sheet - Newser
Is Foghorn Therapeutics Inc. meeting your algorithmic filter criteriaAI Model Forecasting Reversal and Breakout Zones - Newser
Can technical indicators confirm Foghorn Therapeutics Inc.’s reversalStock Market Watch with Smart Filters - Newser
Research Analysts Offer Predictions for FHTX Q3 Earnings - Defense World
Will Foghorn Therapeutics Inc. bounce back from current supportAI Driven Swing Trade Forecasting Insight - Newser
Real time alert setup for Foghorn Therapeutics Inc. performanceShort-Term Bounce Forecast for Oversold Stocks - Newser
Top Risks to Consider Before Buying Foghorn Therapeutics Inc. StockChart Scanner for Swing Trade Timing - Newser
What high frequency data says about Foghorn Therapeutics Inc.Free Entry Alert With Low Drawdown Strategy - Newser
Can volume confirm reversal in Foghorn Therapeutics Inc.Value Holding Return Summary With Outlook - Newser
How Foghorn Therapeutics Inc. stock performs during market volatilitySteady Return Plan Based on Data Analysis - Newser
Here's Why Foghorn Therapeutics (FHTX) Looks Ripe for Bottom Fishing - Yahoo Finance
Wedbush Research Analysts Boost Earnings Estimates for FHTX - Defense World
How to recover losses in Foghorn Therapeutics Inc. stockSafe Entry Screening with Data Backed Analysis - Newser
Foghorn Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayHigh Conviction Stock Long-Term Summary - Newser
Is Foghorn Therapeutics Inc. trending in predictive chart modelsFree Community Strategy With High Win Rate - Newser
Q1 Earnings Estimate for FHTX Issued By Wedbush - Defense World
Foghorn Therapeutics (FHTX) Expected to Announce Earnings on Thursday - Defense World
Foghorn Therapeutics Inc. stock prediction for this weekLong Term Stock Growth Plan Suggestions - Newser
Finanzdaten der Foghorn Therapeutics Inc-Aktie (FHTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):